Different infusion durations for preventing platinum‐induced hearing loss in children with cancer

BACKGROUND: Platinum‐based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: van As, Jorrit W, van den Berg, Henk, van Dalen, Elvira C
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2020
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6984653/
https://ncbi.nlm.nih.gov/pubmed/31961948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010885.pub5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker